CVE:VM

Voyageur Pharmaceuticals Competitors

C$0.17

0.00 (0.00 %)

(As of 04/9/2021 03:39 PM ET)

Add

Compare

Today's Range

C$0.17

Now: C$0.17▼

C$0.18

50-Day Range

C$0.17

MA: C$0.20▼

C$0.23

52-Week Range

C$0.04

Now: C$0.17▼

C$0.35

Volume177,108 shs

Average Volume323,113 shs

Market CapitalizationC$14.79 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Voyageur Pharmaceuticals (CVE:VM) Vs. GUN, PGE, EAM, SIR, SOI, and NRN

Should you be buying VM stock or one of its competitors? Companies in the industry of "industrial metals & minerals" are considered alternatives and competitors to Voyageur Pharmaceuticals, including Gunpoint Exploration (GUN), Group Ten Metals (PGE), East Africa Metals (EAM), Serengeti Resources (SIR), Sirios Resources (SOI), and Northern Shield Resources (NRN).

Voyageur Pharmaceuticals vs. Gunpoint Exploration Stock

Voyageur Pharmaceuticals (CVE:VM) and Gunpoint Exploration (CVE:GUN) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.

Analyst Recommendations

This is a summary of recent ratings and target prices for Voyageur Pharmaceuticals and Gunpoint Exploration, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Voyageur Pharmaceuticals	0	0	1	0	3.00
Gunpoint Exploration	0	0	0	0	N/A

Voyageur Pharmaceuticals presently has a consensus price target of C$0.39, indicating a potential upside of 129.41%. Given Voyageur Pharmaceuticals' higher possible upside, equities research analysts plainly believe Voyageur Pharmaceuticals is more favorable than Gunpoint Exploration.

Earnings & Valuation

This table compares Voyageur Pharmaceuticals and Gunpoint Exploration's revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Voyageur Pharmaceuticals	N/A	N/A	N/A	C($0.02)	-10.63
Gunpoint Exploration	N/A	N/A	N/A	C$0.02	28.26

Voyageur Pharmaceuticals is trading at a lower price-to-earnings ratio than Gunpoint Exploration, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Voyageur Pharmaceuticals and Gunpoint Exploration's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Voyageur Pharmaceuticals	N/A	N/A	N/A
Gunpoint Exploration	N/A	N/A	N/A

Voyageur Pharmaceuticals vs. Group Ten Metals Stock

Voyageur Pharmaceuticals (CVE:VM) and Group Ten Metals (CVE:PGE) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.

Analyst Recommendations

This is a summary of recent ratings and target prices for Voyageur Pharmaceuticals and Group Ten Metals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Voyageur Pharmaceuticals	0	0	1	0	3.00
Group Ten Metals	0	0	0	0	N/A

Earnings & Valuation

This table compares Voyageur Pharmaceuticals and Group Ten Metals' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Voyageur Pharmaceuticals	N/A	N/A	N/A	C($0.02)	-10.63
Group Ten Metals	N/A	N/A	N/A	C($0.04)	-8.84

Voyageur Pharmaceuticals is trading at a lower price-to-earnings ratio than Group Ten Metals, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Voyageur Pharmaceuticals and Group Ten Metals' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Voyageur Pharmaceuticals	N/A	N/A	N/A
Group Ten Metals	N/A	N/A	N/A

Summary

Voyageur Pharmaceuticals beats Group Ten Metals on 3 of the 4 factors compared between the two stocks.

Voyageur Pharmaceuticals vs. East Africa Metals Stock

Voyageur Pharmaceuticals (CVE:VM) and East Africa Metals (CVE:EAM) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.

Analyst Recommendations

This is a summary of recent ratings and target prices for Voyageur Pharmaceuticals and East Africa Metals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Voyageur Pharmaceuticals	0	0	1	0	3.00
East Africa Metals	0	0	0	0	N/A

Earnings & Valuation

This table compares Voyageur Pharmaceuticals and East Africa Metals' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Voyageur Pharmaceuticals	N/A	N/A	N/A	C($0.02)	-10.63
East Africa Metals	N/A	N/A	N/A	C$0.00	-87.50

East Africa Metals is trading at a lower price-to-earnings ratio than Voyageur Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Voyageur Pharmaceuticals and East Africa Metals' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Voyageur Pharmaceuticals	N/A	N/A	N/A
East Africa Metals	N/A	N/A	N/A

Summary

Voyageur Pharmaceuticals beats East Africa Metals on 3 of the 4 factors compared between the two stocks.

Voyageur Pharmaceuticals vs. Serengeti Resources Stock

Voyageur Pharmaceuticals (CVE:VM) and Serengeti Resources (CVE:SIR) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.

Profitability

This table compares Voyageur Pharmaceuticals and Serengeti Resources' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Voyageur Pharmaceuticals	N/A	N/A	N/A
Serengeti Resources	N/A	N/A	N/A

Earnings & Valuation

This table compares Voyageur Pharmaceuticals and Serengeti Resources' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Voyageur Pharmaceuticals	N/A	N/A	N/A	C($0.02)	-10.63
Serengeti Resources	N/A	N/A	N/A	C($0.06)	-8.60

Voyageur Pharmaceuticals is trading at a lower price-to-earnings ratio than Serengeti Resources, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and target prices for Voyageur Pharmaceuticals and Serengeti Resources, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Voyageur Pharmaceuticals	0	0	1	0	3.00
Serengeti Resources	0	0	0	0	N/A

Summary

Voyageur Pharmaceuticals beats Serengeti Resources on 3 of the 4 factors compared between the two stocks.

Voyageur Pharmaceuticals vs. Sirios Resources Stock

Voyageur Pharmaceuticals (CVE:VM) and Sirios Resources (CVE:SOI) are both small-cap basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

Profitability

This table compares Voyageur Pharmaceuticals and Sirios Resources' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Voyageur Pharmaceuticals	N/A	N/A	N/A
Sirios Resources	N/A	N/A	N/A

Valuation and Earnings

This table compares Voyageur Pharmaceuticals and Sirios Resources' top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Voyageur Pharmaceuticals	N/A	N/A	N/A	C($0.02)	-10.63
Sirios Resources	N/A	N/A	N/A	C($0.02)	-6.11

Voyageur Pharmaceuticals is trading at a lower price-to-earnings ratio than Sirios Resources, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Voyageur Pharmaceuticals and Sirios Resources, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Voyageur Pharmaceuticals	0	0	1	0	3.00
Sirios Resources	0	0	1	0	3.00

Voyageur Pharmaceuticals presently has a consensus price target of C$0.39, indicating a potential upside of 129.41%. Sirios Resources has a consensus price target of C$0.41, indicating a potential upside of 272.73%. Given Sirios Resources' higher probable upside, analysts plainly believe Sirios Resources is more favorable than Voyageur Pharmaceuticals.

Summary

Sirios Resources beats Voyageur Pharmaceuticals on 2 of the 3 factors compared between the two stocks.

Voyageur Pharmaceuticals vs. Northern Shield Resources Stock

Voyageur Pharmaceuticals (CVE:VM) and Northern Shield Resources (CVE:NRN) are both small-cap basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

Profitability

This table compares Voyageur Pharmaceuticals and Northern Shield Resources' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Voyageur Pharmaceuticals	N/A	N/A	N/A
Northern Shield Resources	N/A	N/A	N/A

Valuation and Earnings

This table compares Voyageur Pharmaceuticals and Northern Shield Resources' top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Voyageur Pharmaceuticals	N/A	N/A	N/A	C($0.02)	-10.63
Northern Shield Resources	N/A	N/A	N/A	C($0.01)	-11.67

Northern Shield Resources is trading at a lower price-to-earnings ratio than Voyageur Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Voyageur Pharmaceuticals and Northern Shield Resources, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Voyageur Pharmaceuticals	0	0	1	0	3.00
Northern Shield Resources	0	0	0	0	N/A

Voyageur Pharmaceuticals presently has a consensus price target of C$0.39, indicating a potential upside of 129.41%. Given Voyageur Pharmaceuticals' higher probable upside, analysts plainly believe Voyageur Pharmaceuticals is more favorable than Northern Shield Resources.

Summary

Voyageur Pharmaceuticals beats Northern Shield Resources on 3 of the 4 factors compared between the two stocks.